We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA 483 Finds Deficiencies at Baxter Healthcare Facility
FDA 483 Finds Deficiencies at Baxter Healthcare Facility
FDA’s San Juan district office has found numerous problems at a Baxter sterile drug manufacturing facility in Jayuya, Puerto Rico following a series of inspections in late August through early October.